mouseover effect

Link Your Antibody
to its Fullest

As a trusted CDMO partner, Samsung Biologics is proud to expand its range
of services to include bioconjugation including antibody drug conjugation.

Expected to be operational in 2024, our standalone
bioconjugation facility will be located across from our main manufacturing
site and is supported by the robust GMP systems established for our existing
high-capacity clinical and commercial biologics manufacturing.

Dedicated Facility

  • Expedited DS delivery with flexibility at a single site
  • Expertise in quality and proven operational track record
  • Integrated systems with established tools and procedures
  • Stable supply chain management system
Bio Campus 1, Bio Campus 2, ADC Bio Campus 1, Bio Campus 2, ADC
  • Single-use and stainless steel reactors
    (Up to 500L conjugation train)
  • Full-scope laboratories for Development / QC / MSAT
  • HPAPI facility
  • Occupational Exposure Limit (OEL) target of 5ng/m³

Dependable ADC Service

We offer comprehensive services that range from antibody production and conjugation development to manufacturing.

Development Services

Expedite your timeline and development to clinical supply

Manufacturing process

Maximum flexibility to accommodate various requirements

Analytical Testing

Analytical methods to support ADC DS characterization and release of DS

We are committed to staying at the forefront of advanced ADC technology by making active investments through the
Samsung Life Science Fund and securing future partnerships.
araris araris
Innovative linker-payload toolbox and
conjugation technology
Cutting-edge ADC
development technology
legochembiosciences legochembiosciences
Proprietary ADC platform
brickbio brickbio
Protein engineering
technology for ADC



Your download is ready

Click Download.


Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy


Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.